Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Pharmaceutics 2012, 4(1), 243-251; doi:10.3390/pharmaceutics4010243

Ophthalmic Drug Delivery in Glaucoma—A Review

* ,  and
Received: 14 February 2012; in revised form: 29 February 2012 / Accepted: 14 March 2012 / Published: 21 March 2012
(This article belongs to the Special Issue Ocular Drug Delivery)
View Full-Text   |   Download PDF [96 KB, updated 22 March 2012; original version uploaded 21 March 2012]
Abstract: Glaucoma is a progressive optic neuropathy and medical therapy is the initial option for the treatment of this potentially blinding condition. Topical instillation of eye drops from the bottle is the most common glaucoma drug delivery form. Due to limited permeability of anterior ocular surface, natural clearance and drainage, eye drops contain large amounts of inactive ingredients. Effective penetration enhancers are known as irritants causing ocular discomfort. Although drug efficacy is determined by active ingredients, inactive agents can affect tolerance and can result in conjunctival irritation and hyperemia and influence patients’ adherence and quality of life.
Keywords: glaucoma; pharmacokinetics; drug penetration; topical application glaucoma; pharmacokinetics; drug penetration; topical application
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Januleviciene, I.; Siaudvytyte, L.; Barsauskaite, R. Ophthalmic Drug Delivery in Glaucoma—A Review. Pharmaceutics 2012, 4, 243-251.

AMA Style

Januleviciene I, Siaudvytyte L, Barsauskaite R. Ophthalmic Drug Delivery in Glaucoma—A Review. Pharmaceutics. 2012; 4(1):243-251.

Chicago/Turabian Style

Januleviciene, Ingrida; Siaudvytyte, Lina; Barsauskaite, Ruta. 2012. "Ophthalmic Drug Delivery in Glaucoma—A Review." Pharmaceutics 4, no. 1: 243-251.

Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert